Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2024-09-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate in vitro the impact of a novel anti-inflammatory treatment on costimulatory molecules expressed on monocytes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.

NCT01903642

Inflammatory Disease

TERMINATED NA

Pilot Study to Validate ex Vivo Expression of Specific Biomarkers of Human Resolutive Macrophages

NCT05106075

Inflammation

UNKNOWN NA

Study Inflammation During a 100 Miles

NCT03256006

Inflammatory Response

UNKNOWN

Inflammation and the Host Response to Injury (Trauma)

NCT00257231

Trauma Burns Multiple Organ Failure

COMPLETED

Inflammation and Infection in Trauma, Role in Posttraumatic Complications

NCT00192907

Trauma

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immune-mediated inflammatory disease

Patients with an immune-mediated inflammatory disease. A blood sample is achieved at T0 (no follow-up).

Group Type EXPERIMENTAL

Blood sample

Intervention Type BIOLOGICAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sample

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Immune-mediated inflammatory disease (non-ST segment elevation myocardial infarction, Rheumatoid arthritis, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Crohn's disease, Ulcerative colitis, Cystic fibrosis, Psoriasis, Multiple sclerosis or major depressive episode)
* Patient able to understand the reason of the study
* Patient not opposed to the conservation of biological samples for scientific research